Today: 20 May 2026
Browse Category

NYSE:USO 6 January 2026 - 15 January 2026

Crude oil price tumbles on Iran de-escalation; USO stock slips before the bell

Crude oil price tumbles on Iran de-escalation; USO stock slips before the bell

Crude oil prices fell over 3% Thursday after President Trump said Iran’s protest crackdown was easing, reducing supply fears. Brent dropped to $64.33 a barrel, U.S. crude to $59.96. U.S. inventories rose by 3.4 million barrels last week, while gasoline stocks jumped 9 million. Tanker shipments hit 1.3 billion barrels, the highest since mid-2020, signaling supply is outpacing demand.
15 January 2026
······
Crude oil price stock jumps before the open as Venezuela talks and Iran unrest lift oil-linked shares

Crude oil price stock jumps before the open as Venezuela talks and Iran unrest lift oil-linked shares

Chevron rose 2.6%, Exxon Mobil 3.7%, and ConocoPhillips 5.1% in U.S. premarket trading as oil prices edged up. The White House plans to meet Friday with major oil companies to discuss investment in Venezuela’s energy sector. Brent crude climbed 0.7% to $62.42 a barrel, while WTI gained 0.7% to $58.17. U.S. crude inventories fell by 3.8 million barrels last week, while gasoline stocks rose sharply.
9 January 2026
··········
Crude oil rebounds, but Exxon stock and USO ETF slip in premarket as Venezuela headlines bite

Crude oil rebounds, but Exxon stock and USO ETF slip in premarket as Venezuela headlines bite

USO fell 1% premarket Thursday, Exxon Mobil dropped 2%, and Chevron slipped less than 1%. Brent crude rose to $60.55 in Europe after Trump backed a Russia-sanctions bill. The US seized two Venezuela-linked tankers and reached a deal to import up to $2 billion in Venezuelan crude. Exxon warned lower prices could cut Q4 upstream earnings by up to $1.2 billion.
8 January 2026
·····
Oil ETFs swing on Venezuela shock: USO, BNO track crude as U.S. stockpile data looms

Oil ETFs swing on Venezuela shock: USO, BNO track crude as U.S. stockpile data looms

U.S.-listed crude oil ETFs rose in premarket trade Tuesday, with USO and BNO each up 1.8%. Brent crude climbed 0.5% to $62.06 a barrel after the U.S. captured Venezuela’s President Nicolas Maduro, raising uncertainty over Venezuelan output. Investors await U.S. inventory data for further direction. Analysts expect oil supply to remain ample in 2026 despite the Venezuela shock.
6 January 2026
··

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Go toTop